Assignee
NODTHERA LTD
GB·6 granted patents·9 pending applications·5 citations·filing 2018–2025
Top patents by PatentIndex Score
15 records- 0190US12012397B2Sulphonyl urea derivatives as NLRP3 inflammasome modulatorsNODTHERA LTD·Filed 2022·Granted Jun 18, 2024·1 cites·20 claims
- 0288US11518757B2Sulphonyl urea derivatives as NLRP3 inflammasome modulatorsNODTHERA LTD·Filed 2018·Granted Dec 6, 2022·4 cites·21 claims
- 0382US12459925B2Sulphonyl urea derivatives as NLRP3 inflammasome modulatorsNODTHERA LTD·Filed 2024·Granted Nov 4, 2025·0 cites·20 claims
- 0469US2025206745A1Pyrrolopyridazine derivatives and related usesNODTHERA LTD·Filed 2024·Application pending·0 cites
- 0567US2025115558A1Pyridazine derivatives and related usesNODTHERA LTD·Filed 2024·Application pending·0 cites
- 0662US2026008780A1Substituted 3,4-dihydroisoquinolin-1(2h)-one derivatives and related usesNODTHERA LTD·Filed 2023·Application pending·0 cites
- 0761US2025066369A1Bicyclic phthalazin-1(2h)-one derivatives and related usesNODTHERA LTD·Filed 2023·Application pending·0 cites
- 0855US2024043410A1Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereofNODTHERA LTD·Filed 2021·Application pending·0 cites
- 0953US12247011B2Selective inhibitors of NLRP3 inflammasomeNODTHERA LTD·Filed 2018·Granted Mar 11, 2025·0 cites·18 claims
- 1053US12054461B2Sulfonylurea derivatives and uses thereofNODTHERA LTD·Filed 2020·Granted Aug 6, 2024·0 cites·18 claims
- 1153US2025223263A1Selective inhibitors of nlrp3 inflammasomeNODTHERA LTD·Filed 2025·Application pending·0 cites
- 1250US2022098159A1Carbamate derivatives and uses thereofNODTHERA LTD·Filed 2020·Application pending·0 cites
- 1350US2023083495A1Sulfonylurea derivatives and uses thereofNODTHERA LTD·Filed 2020·Application pending·0 cites
- 1448US2022267300A1Sulfonamide derivatives and uses thereofNODTHERA LTD·Filed 2020·Application pending·0 cites
- 1534US11345669B2Urea derivatives and methods of use thereofNODTHERA LTD·Filed 2018·Granted May 31, 2022·0 cites·20 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →